Cargando…

Clindamycin Plus Vancomycin Versus Linezolid for Treatment of Necrotizing Soft Tissue Infection

BACKGROUND: Necrotizing soft tissue infections (NSTIs) are life-threatening infections. The aim of this study is to evaluate the safety of clindamycin plus vancomycin versus linezolid as empiric treatment of NSTIs. METHODS: This was a retrospective, single-center, quasi-experimental study of patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dorazio, Joshua, Chiappelli, Abby L, Shields, Ryan K, Tsai, Y Vivian, Skinker, Peyton, Nabozny, Michael J, Bauza, Graciela, Forsythe, Raquel, Rosengart, Matthew R, Gunn, Scott R, Marini, Rachel, Clarke, Lloyd, Falcione, Bonnie, Ludwig, Justin, McCreary, Erin K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284335/ https://www.ncbi.nlm.nih.gov/pubmed/37351452 http://dx.doi.org/10.1093/ofid/ofad258

Ejemplares similares

Immediate and Delayed Hypersensitivity Reactions to Antibiotics: Aminoglycosides, Clindamycin, Linezolid, and Metronidazole
por: Dilley, Michelle, et al.
Publicado: (2021)

1370. Role of Clindamycin Versus Linezolid for Serious Group A Streptococcal Infections
por: Heil, Emily, et al.
Publicado: (2021)

Linezolid vs Vancomycin in Induced Thrombocytopenia
por: Al-Harbi, Dimah, et al.
Publicado: (2022)

Activity of vancomycin combined with linezolid against clinical vancomycin-resistant Enterococcus strains
por: Aktas, Gulseren
Publicado: (2020)

Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin
por: Estes, Kerry S, et al.
Publicado: (2010)

Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol
por: Zarogoulidis, Paul, et al.
Publicado: (2014)

Intravitreal linezolid in the management of vancomycin-resistant enterococcal endophthalmitis
por: Babalola, Olufemi Emmanuel
Publicado: (2020)

Nanobiotic formulations as promising advances for combating MRSA resistance: susceptibilities and post-antibiotic effects of clindamycin, doxycycline, and linezolid
por: Mohamed, Mennatallah A., et al.
Publicado: (2021)

Comparison of linezolid and daptomycin for the treatment of vancomycin-resistant enterococcal bacteremia
por: Narayanan, Navaneeth, et al.
Publicado: (2019)

89. Efficacy and Tolerability of Voriconazole (VOR) vs. Isavuconazole (ISA) Prophylaxis (px) in Preventing Invasive Fungal Infections (IFI) in Lung Transplant Recipients (LTR)
por: Samanta, Palash, et al.
Publicado: (2019)

Linezolid to treat urinary tract infections caused by vancomycin-resistant Enterococcus
por: Pontefract, Benjamin Alan, et al.
Publicado: (2020)

Optimization of Linezolid Dosing Regimens for Treatment of Vancomycin-Resistant Enterococci Infection
por: Santimaleeworagun, Wichai, et al.
Publicado: (2021)

Linezolid for the Treatment of Urinary Tract Infections Caused by Vancomycin-Resistant Enterococci
por: Wingler, Mary Joyce, et al.
Publicado: (2021)

1462. Analysis of Clindamycin and Vancomycin Use and Reported Beta Lactam Allergy in Procedural Antimicrobial Prophylaxis
por: Veach, Lisa A, et al.
Publicado: (2023)

Pneumonia Caused by Community-Acquired Methicillin-Resistant Staphylococcus aureus: Vancomycin or Linezolid?
por: Tian, Ye, et al.
Publicado: (2018)

1470. Linezolid for Treatment of Urinary Tract Infections Caused by Vancomycin-resistant Enterococci
por: Pontefract, Benjamin, et al.
Publicado: (2019)

Effectiveness, safety, and cost of vancomycin and linezolid in Kuwait: A retrospective cohort study
por: Alghanem, Sarah S., et al.
Publicado: (2023)

Successful Treatment of Necrotizing Fasciitis and Streptococcal Toxic Shock Syndrome with the Addition of Linezolid
por: Rac, Hana, et al.
Publicado: (2017)

Stewardship-Guided T2Candida Testing Shortens Time to Antifungal Treatment and Reduces Antifungal Usage Among Medical Intensive Care Unit Patients With Septic Shock
por: O’Donnell, Matthew, et al.
Publicado: (2023)

In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci
por: El-Azizi, Mohamed, et al.
Publicado: (2005)

Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis
por: Kalil, Andre C, et al.
Publicado: (2013)

Disposition of linezolid or daptomycin in Enterococcal bloodstream infections according to vancomycin resistant Enterococcus colonization
por: Short, Elizabeth, et al.
Publicado: (2014)

No Outbreak of Vancomycin and Linezolid Resistance in Staphylococcal Pneumonia over a 10-Year Period
por: Yayan, Josef, et al.
Publicado: (2015)

Retrospective Study of Linezolid vs. Daptomycin for the Treatment of Vancomycin--resistant Enterococcal Bloodstream Infection
por: Rai, Rena, et al.
Publicado: (2017)

1045 Linezolid Compared to Daptomycin for the Treatment of Vancomycin-resistant Enterococcal Urinary Tract Infections
por: Moenster, Ryan P., et al.
Publicado: (2014)

Risk Factors and Outcomes Associated With Acquisition of Daptomycin and Linezolid–Nonsusceptible Vancomycin-Resistant Enterococcus
por: Greene, Matthew H, et al.
Publicado: (2018)

Comparative efficacy of linezolid and vancomycin for endotracheal tube MRSA biofilms from ICU patients
por: Fernández-Barat, Laia, et al.
Publicado: (2019)

Device-Associated Meningitis by Linezolid-Resistant Staphylococcus haemolyticus in a Vancomycin- Hypersensitive Patient
por: Vijayan, Priya, et al.
Publicado: (2019)

A Nanoplex PCR Assay for the Simultaneous Detection of Vancomycin- and Linezolid-Resistant Genes in Enterococcus
por: Wada, Yusuf, et al.
Publicado: (2023)

Vancomycin and Linezolid-Resistant Enterococcus Isolates from a Tertiary Care Center in India
por: Sengupta, Mallika, et al.
Publicado: (2023)

Case report of clindamycin graded challenge in an AIDS patient allergic to clindamycin
por: Raknoo, Thitinun, et al.
Publicado: (2022)

Sub-Inhibitory Concentrations of Oxacillin, but Not Clindamycin, Linezolid, or Tigecycline, Decrease Staphylococcal Phenol-Soluble Modulin Expression in Community-Acquired Methicillin-Resistant Staphylococcus aureus
por: Hodille, Elisabeth, et al.
Publicado: (2022)

175. Clindamycin versus linezolid for Group A Streptococcal bloodstream infections?: A comparative effectiveness study of adjunctive antitoxin therapy at 137 US Hospitals
por: Babiker, Ahmed, et al.
Publicado: (2023)

Clindamycin suppresses virulence expression in inducible clindamycin-resistant Staphylococcus aureus strains
por: Hodille, Elisabeth, et al.
Publicado: (2018)

Toxin A and B genes expression of Clostridium difficile in the sub-minimum inhibitory concentration of clindamycin, vancomycin and in combination with ceftazidime
por: Moradi, Mohammad, et al.
Publicado: (2020)

Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus meningitis in an experimental rabbit model
por: Calik, Sebnem, et al.
Publicado: (2012)

In vitro susceptibility to methicillin, vancomycin and linezolid of staphylococci isolated from bloodstream infections in eastern Turkey
por: Tekin, Alicem, et al.
Publicado: (2014)

Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis
por: Chuang, Yu-Chung, et al.
Publicado: (2014)

Comparative-effectiveness of vancomycin and linezolid as part of guideline-recommended empiric therapy for healthcare-associated pneumonia
por: Reveles, Kelly R., et al.
Publicado: (2015)

Emergence of linezolid- and vancomycin-resistant Enterococcus faecium in a department for hematologic stem cell transplantation
por: Krull, M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4oistd6gtmvkvrnd75qfv7n7qd